Defining new reference intervals for serum free light chains in individuals with chronic kidney disease : Results of the iStopMM study
Funding Information: Dr. Landgren has received grant support from: NCI/NIH, FDA, LLS, Rising Tide Foundation, Memorial Sloan Kettering Cancer Center, MMRF, IMF, Paula, and Rodger Riney Foundation, Perelman Family Foundation, Amgen, Celgene, Janssen, Takeda, Glenmark, Seattle Genetics, Karyopharm; ha...
Full description
Bibliographic Details
Published in: | Blood Cancer Journal |
Main Authors: |
Long, Þórir Einarsson,
Indriðason, Ólafur Skúli,
Pálsson, Runólfur,
Rögnvaldsson, Sæmundur,
Löve, Þorvarður Jón,
Thorsteinsdóttir, Sigrún,
Sverrisdóttir, Ingigerður S,
Viðarsson, Brynjar,
Önundarson, Páll Torfi,
Agnarsson, Bjarni Agnar,
Sigurðardóttir, Margrét,
Þorsteinsdóttir, Ingunn,
Ólafsson, Ísleifur,
Thordardottir, Asdis Rosa,
Eyþórsson, Elías Sæbjörn,
Jónsson, Ásbjörn,
Gíslason, Gauti Kjartan,
Ólafsson, Andri,
Steingrímsdóttir, Hlíf,
Hultcrantz, Malin,
Durie, Brian G.M.,
Harding, Stephen,
Landgren, Ola,
Kristinsson, Sigurður Yngvi |
Other Authors: |
Internal Medicine and Emergency Services,
Other departments,
Faculty of Medicine,
Clinical Laboratory Services, Diagnostics and Blood Bank,
Office of Division of Clinical Services II,
Cancer Center,
University of Iceland,
Landspitali - The National University Hospital of Iceland |
Format: | Article in Journal/Newspaper
|
Language: | English |
Published: |
2022
|
Subjects: |
|
Online Access: | https://hdl.handle.net/20.500.11815/3484
https://doi.org/10.1038/s41408-022-00732-3
|